On Demand: Scaling Excellence in Cardiac PET/CT: Lessons From the Field-Presentation Slides

Presentation Slides

Pdf Summary

The 2025 MedAxiom presentation, titled "Scaling Excellence in Cardiac PET: Lessons from the Field," focuses on the clinical superiority, value, and implementation strategies of cardiac Positron Emission Tomography (PET) imaging. Dr. Rupa Sanghani, an expert in nuclear cardiology, highlights cardiac PET's advantages over traditional imaging like SPECT, emphasizing its consistent high-quality, high-resolution images, superior diagnostic accuracy, and its ability to reduce follow-up testing. Cardiac PET offers comprehensive risk assessment, including evaluation of myocardial blood flow reserve (MBFR), capturing both macrovascular and microvascular coronary dysfunction. PET is preferred for patients with known or suspected coronary artery disease (CAD), especially when exercise stress imaging is not feasible, and is invaluable for evaluating myocardial viability, cardiac sarcoidosis, inflammatory cardiac conditions, and myocardial perfusion.<br /><br />The case studies illustrate cardiac PET's ability to detect high-risk features such as balanced ischemia and abnormal MBFR even with normal or mild perfusion abnormalities, reinforcing its clinically impactful reclassification of patient risk.<br /><br />The presentation also addresses common barriers to implementing PET programs, such as cost, regulatory approvals, and staffing. Success factors include building multidisciplinary teams, efficient workflows, prioritizing staff training on myocardial blood flow measurements, and adopting mobile or flexible PET solutions to overcome infrastructure challenges.<br /><br />CDL Nuclear Technologies offers tailored solutions ranging from fixed cardiac PET/CT suite buildouts to mobile cardiac PET/CT services and on-demand mobile rubidium generators. These services facilitate rapid deployment, reduced costs, and operational efficiencies. The adoption of cardiac PET is growing rapidly, with a projected 20% annual growth rate through 2029 due to stable reimbursement, evolving physician preferences, and technological advances.<br /><br />Key takeaways emphasize the clinical excellence of cardiac PET/CT as the gold standard, the importance of thoughtful implementation, flexible partnerships, and continued investment in training and workflow integration to fully realize PET's benefits in cardiac care.

Keywords

Cardiac PET

Positron Emission Tomography

Myocardial Blood Flow Reserve

Coronary Artery Disease

Cardiac Sarcoidosis

Diagnostic Accuracy

PET Implementation Strategies

Mobile PET Solutions

Nuclear Cardiology

Cardiac Imaging Technology